Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Survival of children after liver transplantation for hepatocellular carcinoma.

Baumann U, Adam R, Duvoux C, Mikolajczyk R, Karam V, D'Antiga L, Chardot C, Coker A, Colledan M, Ericzon BG, Line PD, Hadzic N, Isoniemi H, Klempnauer JL, Reding R, McKiernan PJ, McLin V, Paul A, Salizzoni M, Furtado ESB, Schneeberger S, Karch A; European Liver and Intestine Transplant Association.

Liver Transpl. 2018 Feb;24(2):246-255. doi: 10.1002/lt.24994.

PMID:
29222922
2.

Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients.

Wange N, Anan I, Ericzon BG, Pennlert J, Pilebro B, Suhr OB, Wixner J.

Transplantation. 2018 Feb;102(2):e59-e66. doi: 10.1097/TP.0000000000001975.

3.

Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue.

Rådestad E, Egevad L, Jorns C, Mattsson J, Sundberg B, Nava S, Ericzon BG, Henningsohn L, Levitsky V, Uhlin M.

Oncotarget. 2017 Jul 24;8(36):60257-60269. doi: 10.18632/oncotarget.19528. eCollection 2017 Sep 1.

4.

Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades.

Nordin A, Åberg F, Pukkala E, Pedersen CR, Storm HH, Rasmussen A, Bennet W, Olausson M, Wilczek H, Ericzon BG, Tretli S, Line PD, Karlsen TH, Boberg KM, Isoniemi H.

Am J Transplant. 2017 Sep 19. doi: 10.1111/ajt.14507. [Epub ahead of print]

PMID:
28925583
5.

Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.

Muller X, Marcon F, Sapisochin G, Marquez M, Dondero F, Rayar M, Doyle MMB, Callans L, Li J, Nowak G, Allard MA, Jochmans I, Jacskon K, Beltrame MC, van Reeven M, Iesari S, Cucchetti A, Sharma H, Staiger RD, Raptis DA, Petrowsky H, de Oliveira M, Hernandez-Alejandro R, Pinna AD, Lerut J, Polak WG, de Santibañes E, de Santibañes M, Cameron AM, Pirenne J, Cherqui D, Adam RA, Ericzon BG, Nashan B, Olthoff K, Shaked A, Chapman WC, Boudjema K, Soubrane O, Paugam-Burtz C, Greig PD, Grant DR, Carvalheiro A, Muiesan P, Dutkowski P, Puhan M, Clavien PA.

Ann Surg. 2018 Mar;267(3):419-425. doi: 10.1097/SLA.0000000000002477.

PMID:
28885508
6.

Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.

Navarro D, San-Juan R, Manuel O, Giménez E, Fernández-Ruiz M, Hirsch HH, Grossi PA, Aguado JM; ESGICH CMV Survey Study Group, on behalf of the European Study Group of Infections in Compromised Hosts (ESGICH) from the Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12773. Epub 2017 Oct 25.

PMID:
28859257
7.

Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study.

Ganschow R, Ericzon BG, Dhawan A, Sharif K, Martzloff ED, Rauer B, Ng J, Lopez P.

Pediatr Transplant. 2017 Nov;21(7). doi: 10.1111/petr.13024. Epub 2017 Jul 17.

PMID:
28714558
8.

Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression.

Karadagi A, Johansson H, Zemack H, Salipalli S, Mörk LM, Kannisto K, Jorns C, Gramignoli R, Strom S, Stokkeland K, Ericzon BG, Jonigk D, Janciauskiene S, Nowak G, Ellis ECS.

PLoS One. 2017 May 9;12(5):e0177279. doi: 10.1371/journal.pone.0177279. eCollection 2017.

9.

Domino liver transplantation: full-length transthyretin in donor and recipient patients with ATTR Val30Met amyloidosis.

Westermark P, Nowak G, Suhr OB, Ericzon BG.

Amyloid. 2017 Mar;24(sup1):128-129. doi: 10.1080/13506129.2017.1294058. No abstract available.

PMID:
28434334
10.

Pharmacokinetics of prolonged-release tacrolimus versus immediate-release tacrolimus in de novo liver transplantation: A randomized phase III substudy.

Ericzon BG, Varo E, Trunečka P, Fischer L, Colledan M, Gridelli B, Valdivieso A, O'Grady J, Dickinson J, Undre N.

Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12958. Epub 2017 Apr 27.

PMID:
28295581
11.

Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.

Lai Q, Feys E, Karam V, Adam R, Klempnauer J, Oliverius M, Mazzaferro V, Pascher A, Remiszewski P, Isoniemi H, Pirenne J, Foss A, Ericzon BG, Markovic S, Lerut JP; European Liver Intestine Transplant Association (ELITA).

Transplantation. 2017 Mar;101(3):555-564. doi: 10.1097/TP.0000000000001603.

PMID:
28212256
12.

Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation.

Wadström J, Ericzon BG, Halloran PF, Bechstein WO, Opelz G, Serón D, Grinyó J, Loupy A, Kuypers D, Mariat C, Clancy M, Jardine AG, Guirado L, Fellström B, O'Grady J, Pirenne J, O'Leary JG, Aluvihare V, Trunečka P, Baccarani U, Neuberger J, Soto-Gutierrez A, Geissler EK, Metzger M, Gray M.

Transplantation. 2017 Feb;101 Suppl 2S:S1-S41. doi: 10.1097/TP.0000000000001563. No abstract available.

PMID:
28125449
13.

Impaired intention-to-treat survival after listing for liver transplantation in children with biliary atresia compared to other chronic liver diseases: 20 years' experience from the Nordic countries.

Malenicka S, Ericzon BG, Jørgensen MH, Isoniemi H, Karlsen TH, Krantz M, Naeser V, Olausson M, Rasmussen A, Rönnholm K, Sanengen T, Scholz T, Fischler B, Nemeth A.

Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12851. Epub 2016 Dec 13.

PMID:
27957786
14.

Current and future treatment of amyloid diseases.

Ankarcrona M, Winblad B, Monteiro C, Fearns C, Powers ET, Johansson J, Westermark GT, Presto J, Ericzon BG, Kelly JW.

J Intern Med. 2016 Aug;280(2):177-202. doi: 10.1111/joim.12506. Epub 2016 May 10. Review.

15.

Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.

Omazic B, Remberger M, Barkholt L, Söderdahl G, Potácová Z, Wersäll P, Ericzon BG, Mattsson J, Ringdén O.

Biol Blood Marrow Transplant. 2016 Apr;22(4):676-681. doi: 10.1016/j.bbmt.2015.12.017. Epub 2015 Dec 29.

16.

Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.

Suhr OB, Larsson M, Ericzon BG, Wilczek HE; FAPWTRʼs investigators.

Transplantation. 2016 Feb;100(2):373-81. doi: 10.1097/TP.0000000000001021.

17.

De Novo Donor-Specific HLA Antibody Formation in Two Patients With Crigler-Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning.

Jorns C, Nowak G, Nemeth A, Zemack H, Mörk LM, Johansson H, Gramignoli R, Watanabe M, Karadagi A, Alheim M, Hauzenberger D, van Dijk R, Bosma PJ, Ebbesen F, Szakos A, Fischler B, Strom S, Ellis E, Ericzon BG.

Am J Transplant. 2016 Mar;16(3):1021-30. doi: 10.1111/ajt.13487. Epub 2015 Nov 2.

18.

Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?

Ericzon BG, Wilczek HE, Larsson M, Wijayatunga P, Stangou A, Pena JR, Furtado E, Barroso E, Daniel J, Samuel D, Adam R, Karam V, Poterucha J, Lewis D, Ferraz-Neto BH, Cruz MW, Munar-Ques M, Fabregat J, Ikeda S, Ando Y, Heaton N, Otto G, Suhr O.

Transplantation. 2015 Sep;99(9):1847-54. doi: 10.1097/TP.0000000000000574.

PMID:
26308415
19.

Cyclosporin A, but not tacrolimus, negatively affects the hepatic extraction fraction of hepatobiliary scintigraphy in liver transplant recipients.

Kaxiras A, Yamamoto S, Söderdahl G, Wernerson A, Axelsson R, Ericzon BG.

EJNMMI Res. 2014 Dec;4(1):73. doi: 10.1186/s13550-014-0073-z. Epub 2014 Dec 17.

20.

Post hoc analysis of nutritional status in patients with transthyretin familial amyloid polyneuropathy: impact of tafamidis.

Suhr OB, Conceição IM, Karayal ON, Mandel FS, Huertas PE, Ericzon BG.

Neurol Ther. 2014 Dec 11;3(2):101-12. doi: 10.1007/s40120-014-0023-8. eCollection 2014 Dec.

Supplemental Content

Loading ...
Support Center